Literature DB >> 21613932

Progress toward improving animal models for idiopathic pulmonary fibrosis.

Amber L Degryse1, William E Lawson.   

Abstract

Idiopathic pulmonary fibrosis (IPF) remains a disease with an unknown cause and a poor prognosis. Among attempts to define disease pathogenesis, animal models of experimental lung fibrosis have a prominent role. Commonly used models include exposure to bleomycin, silica, fluorescein isothiocyanate; irradiation; or expression of specific genes through a viral vector or transgenic system. These all have been instrumental in the study of lung fibrosis, but all have limitations and fall short of recapitulating a pattern of usual interstitial pneumonia, the pathologic correlate to IPF. A model of repetitive bleomycin lung injury has recently been reported that results in marked lung fibrosis, prominent alveolar epithelial cell hyperplasia, a pattern of temporal heterogeneity and persistence of aberrant remodeling well after stimulus removal, representing a significant addition to the collection of animal lung fibrosis models. Taken together, animal models remain a key component in research strategies to better define IPF pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613932      PMCID: PMC3103078          DOI: 10.1097/MAJ.0b013e31821aa000

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  32 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

Authors:  M Kolb; P J Margetts; D C Anthony; F Pitossi; J Gauldie
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

3.  Role of repeated lung injury and genetic background in bleomycin-induced fibrosis.

Authors:  Man Pyo Chung; Martha M Monick; Nabeel Y Hamzeh; Noah S Butler; Linda S Powers; Gary W Hunninghake
Journal:  Am J Respir Cell Mol Biol       Date:  2003-04-03       Impact factor: 6.914

Review 4.  Pulmonary toxicity of antitumor agents.

Authors:  F M Muggia; A C Louie; B I Sikic
Journal:  Cancer Treat Rev       Date:  1983-12       Impact factor: 12.111

5.  Induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell-dependent.

Authors:  P J Christensen; R E Goodman; L Pastoriza; B Moore; G B Toews
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.

Authors:  Amber L Degryse; Harikrishna Tanjore; Xiaochuan C Xu; Vasiliy V Polosukhin; Brittany R Jones; Frank B McMahon; Linda A Gleaves; Timothy S Blackwell; William E Lawson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-18       Impact factor: 5.464

Review 7.  Idiopathic pulmonary fibrosis.

Authors:  T J Gross; G W Hunninghake
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

8.  Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation.

Authors:  C E Rube; D Uthe; K W Schmid; K D Richter; J Wessel; A Schuck; N Willich; C Rube
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

9.  Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis.

Authors:  William D Hardie; Timothy D Le Cras; Kenny Jiang; Jay W Tichelaar; Mohamad Azhar; Thomas R Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-12-05       Impact factor: 5.464

10.  Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis.

Authors:  Chun Geun Lee; Soo Jung Cho; Min Jong Kang; Svetlana P Chapoval; Patty J Lee; Paul W Noble; Teshome Yehualaeshet; Binfeng Lu; Richard A Flavell; Jeffrey Milbrandt; Robert J Homer; Jack A Elias
Journal:  J Exp Med       Date:  2004-08-02       Impact factor: 14.307

View more
  57 in total

Review 1.  Mitochondrial DNA damage and its consequences for mitochondrial gene expression.

Authors:  Susan D Cline
Journal:  Biochim Biophys Acta       Date:  2012-06-19

2.  Type 2 alveolar cells are stem cells in adult lung.

Authors:  Christina E Barkauskas; Michael J Cronce; Craig R Rackley; Emily J Bowie; Douglas R Keene; Barry R Stripp; Scott H Randell; Paul W Noble; Brigid L M Hogan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

3.  Periostin Deficiency Causes Severe and Lethal Lung Injury in Mice With Bleomycin Administration.

Authors:  Hirofumi Kondoh; Takashi Nishiyama; Yoshinao Kikuchi; Masashi Fukayama; Mitsuru Saito; Isao Kii; Akira Kudo
Journal:  J Histochem Cytochem       Date:  2016-06-07       Impact factor: 2.479

4.  Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.

Authors:  Taku Nakashima; Tianju Liu; Biao Hu; Zhe Wu; Matthew Ullenbruch; Keitaro Omori; Lin Ding; Noboru Hattori; Sem H Phan
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

5.  An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.

Authors:  Arnold S Kristof; Basil J Petrof; Qutayba Hamid; Martin Kolb; Jennifer S Landry; Alex MacKenzie; Francis X McCormack; Inga J Murawski; Joel Moss; Frank Rauch; Ivan O Rosas; Adam J Shapiro; Benjamin M Smith; David Y Thomas; Bruce C Trapnell; Lisa R Young; Maimoona A Zariwala
Journal:  Ann Am Thorac Soc       Date:  2017-08

Review 6.  Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.

Authors:  Marek Barczyk; Matthias Schmidt; Sabrina Mattoli
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

7.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.

Authors:  Jason R Rock; Christina E Barkauskas; Michael J Cronce; Yan Xue; Jeffrey R Harris; Jiurong Liang; Paul W Noble; Brigid L M Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

8.  Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.

Authors:  Rebecca Lee; Charles Reese; Michael Bonner; Elena Tourkina; Zoltan Hajdu; Ellen C Riemer; Richard M Silver; Richard P Visconti; Stanley Hoffman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-28       Impact factor: 5.464

9.  Radiation fibrosis of the vocal fold: from man to mouse.

Authors:  Michael M Johns; Vasantha Kolachala; Eric Berg; Susan Muller; Frances X Creighton; Ryan C Branski
Journal:  Laryngoscope       Date:  2012-12       Impact factor: 3.325

Review 10.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.